BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1338666)

  • 21. [Morphology of dysplasia and small cancer of the breast].
    Ermilova VD; Zolotarevskiĭ VB; Delektorskaia VV; Raĭkhlin NT
    Arkh Patol; 1985; 47(11):43-51. PubMed ID: 3004395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary lesions of the breast.
    Ibarra JA
    Breast J; 2006; 12(3):237-51. PubMed ID: 16684322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis.
    Rakha EA; Gandhi N; Climent F; van Deurzen CH; Haider SA; Dunk L; Lee AH; Macmillan D; Ellis IO
    Am J Surg Pathol; 2011 Aug; 35(8):1093-103. PubMed ID: 21753694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathological types of breast cancer in Nigerian women: a 12-year review (1993-2004).
    Ekanem VJ; Aligbe JU
    Afr J Reprod Health; 2006 Apr; 10(1):71-5. PubMed ID: 16999196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast ductal carcinoma in situ with microinvasion: a definition supported by a long-term study of 1248 serially sectioned ductal carcinomas.
    de Mascarel I; MacGrogan G; Mathoulin-Pélissier S; Soubeyran I; Picot V; Coindre JM
    Cancer; 2002 Apr; 94(8):2134-42. PubMed ID: 12001109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New aspects of the natural history of in situ and invasive carcinoma in the female breast. Results from autopsy investigations.
    Andersen J; Nielsen M; Christensen L
    Verh Dtsch Ges Pathol; 1985; 69():88-95. PubMed ID: 3006395
    [No Abstract]   [Full Text] [Related]  

  • 27. [Management of ductal carcinoma in situ by the pathologist: current questions].
    Arnould L; Caron Y; Sigal-Zafrani B
    Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Procedures of analytic morphometry in the monitoring of nuclear changes of breast ductal epithelium from normal to carcinoma].
    Giardina C; Serio G; Potente F; Pennella A; Lettini T; Di Tolve P; Ricco R; Pesce Delfino V
    Pathologica; 1992; 84(1094):97-100. PubMed ID: 1338654
    [No Abstract]   [Full Text] [Related]  

  • 30. The pathologic profile of invasive breast cancer-ii) changes in the harboring mammary tissue and regional lymphnodes.
    Mehtani VG; Joshi K; Mehrotra GC
    Indian J Pathol Microbiol; 1987 Oct; 30(4):415-22. PubMed ID: 2853136
    [No Abstract]   [Full Text] [Related]  

  • 31. Nipple aspirate fluid cytology in breast carcinoma.
    Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
    Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of occult invasive breast cancer after excisional biopsy showing in-situ ductal carcinoma of comedo pattern.
    Hardman PD; Worth A; Lee U; Baird RM
    Can J Surg; 1989 Jan; 32(1):56-60. PubMed ID: 2535949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
    Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
    Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Histologic classification of breast cancer and its precancerous stages].
    Nizze H
    Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.
    Skalova A; Ryska A; Kajo K; Di Palma S; Kinkor Z; Michal M
    Histopathology; 2005 Jan; 46(1):43-9. PubMed ID: 15656885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma.
    Eusebi V; Foschini MP; Cook MG; Berrino F; Azzopardi JG
    Semin Diagn Pathol; 1989 May; 6(2):165-73. PubMed ID: 2548274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The so-called minimal cancers of the breast (author's transl)].
    Andry G; Mendes da Costa PW; Vandenheule B; Mattheiem W
    Acta Chir Belg; 1977; 76(4):453-6. PubMed ID: 200040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the clinicopathological characteristics and prognosis in 674 cases of breast intraductal papillary tumor].
    Wang WY; Wang X; Gao JD; Wang J; Liu JQ; Wang X; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):429-433. PubMed ID: 28635232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.